Verastem (VSTM) Change in Receivables (2018 - 2026)
Verastem (VSTM) recorded quarterly Change in Receivables of $1.3 million in Q1 2026, down 35.86% quarter-over-quarter from $2.1 million in Q4 2025.
Verastem (VSTM) Change in Receivables (2018 - 2026) Analysis & Trends
Verastem's Change in Receivables history runs 8 years deep, the most recent figure standing at $1.3 million for Q1 2026.
- In Q1 2026, Change in Receivables changed N/A year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $8.1 million (changed N/A YoY), while the FY2025 annual figure was $8.8 million, changed N/A from the prior year.
- Change in Receivables was $1.3 million for Q1 2026 at Verastem, down from $2.1 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $4.6 million in Q3 2025 to a low of -$2.5 million in Q2 2022.
- Historically, Change in Receivables has averaged $756600.0 across 4 years, with a median of $0.0 in 2023.
- Biggest YoY gain for Change in Receivables was 140.18% in 2022; the steepest drop was 287.21% in 2022.
- A 4-year view of Change in Receivables shows it stood at -$43000.0 in 2022, then jumped by 95.35% to -$2000.0 in 2023, then soared by 104950.0% to $2.1 million in 2025, then sank by 35.86% to $1.3 million in 2026.
- The last three Change in Receivables figures came in at $1.3 million (Q1 2026), $2.1 million (Q4 2025), and $4.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -4.08 Mn |
| 10 | Verastem | 407.42 Mn | 225.74 Mn | 15.90 Mn | 1.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.35 Mn |
| Mar 31, 2026 | 1.35 Mn |
| Dec 31, 2025 | 2.10 Mn |
| Dec 31, 2025 | 2.10 Mn |
| Sep 30, 2025 | 4.64 Mn |
| Sep 30, 2025 | 4.64 Mn |
| Sep 30, 2023 | -2,000.00 |
| Sep 30, 2023 | -2,000.00 |
| Jun 30, 2023 | 2,000.00 |
| Jun 30, 2023 | 2,000.00 |
| Mar 31, 2023 | -31,000.00 |
| Mar 31, 2023 | -31,000.00 |
| Dec 31, 2022 | -43,000.00 |
| Dec 31, 2022 | -43,000.00 |
| Sep 30, 2022 | -57,000.00 |
| Sep 30, 2022 | -57,000.00 |
| Jun 30, 2022 | -2.51 Mn |
| Jun 30, 2022 | -2.51 Mn |
| Mar 31, 2022 | 2.13 Mn |
| Mar 31, 2022 | 2.13 Mn |